 Chandler
R. Dawson, MD
Contact Information
95 Kirkham Box 0412
San Francisco, CA 94143-0412
Education
AB: Princeton University
MD: Yale University
Intern: North Carolina Memorial Hospital, University of North
Carolina
Senior Assistant Surgeon: Centers for Disease Control and
Prevention
Research Fellowship: Francis I. Proctor Foundation
Research Interests
Infectious and Inflammatory Ocular Disease—Dr. Margolis' clinical experience is in the medical and
surgical management of infectious and inflammatory ocular
disease with a particular interest in high-risk keratoplasty,
cataract extraction in patients with uveitis, ocular disease
due to the herpes viruses, and AIDS-associated ocular infections.
His clinical research is aimed at understanding the pathogenic
mechanisms leading to atypical presentations of ocular infections.
This work dovetails closely with his laboratory research,
providing valuable clinical samples and raising important
questions that can be addressed at the laboratory bench.
# Cellular Studies of HSV.
Professor Emeritus
Dr. Dawson and colleagues previously evaluated the use of
community-wide treatment with oral azithromycin for infectious
trachoma in Egypt, Tanzania, and The Gambia. They are now
initiating a follow-up study to evaluate the long-term impact
of this treatment in Egypt. This study should provide a rational
approach to the use of azithromycin treatment to eliminate
blinding trachoma as a public health problem.
Representative Publications
Bird M, Dawson CR, Schachter JS, Miao Y, Shama A, Osman
A, Bassem A, Lietman TM. Does the diagnosis of trachoma adequately
identify ocular chlamydial infection in trachoma-endemic areas?
J Infect Dis. 2003. 187:1669-73.
Schachter J, Dawson CR. Elimination of blinding trachoma.
Curr Opin Infect Dis. 2002. 15:491-5.
Dawson CR, Schachter J. Should trachoma be treated with
antibiotics? Lancet. 2002. 59:184-5.
Bain DL, Lietman T, Rasmussen S, Kalman S, Fan J, Lammel
C, Zhang JZ, Dawson CR, Schachter J, Stephens RS. Chlamydial
genovar distribution after community wide antibiotic treatment.
J Infect Dis. 2001. 184:1581-8.
Lietman TM, Dawson CR, Osaki SY, Zegans ME. Clinically active
trachoma versus actual chlamydial infection. Med J Aust. 2000.
172:93-4.
Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey
R, Vitale S, Quinn TC, Sheta A, Sallam S, Mkocha H, Mabey
D, Faal H. Azithromycin in control of trachoma. Lancet. 1999.
354:630-5.
Thygeson P, O'Connor GR, Dawson CR, Whitcher JP, Cunningham
ET Jr. The Francis I. Proctor Foundation: the first fifty
years. Surv Ophthalmol. 1998. 42:548-56.
Dawson CR, Schachter J, Sallam S, Sheta A, Rubinstein RA,
Washton H. A comparison of oral azithromycin with topical
oxytetracycline/polymyxin for the treatment of trachoma in
children. Clin Infect Dis. 1997. 24:363-8. Complete
Medline Listing |
